bioRxivBioengineeringPreprint
An Engineered 3D Co-culture Model of Primary Macrophages and Patient-Derived Tumour Cells to Explore Cellular Responses in the Graded Hypoxic Microenvironment of Pancreatic Cancer
I. L. Co, C. Yu, S. Lamorte, M. T. Ciudad, N. Landon-Brace, J. L. Cadavid, Z. Xia, A. Fomina, M. Nurse, T. L. McGaha, K. R. Campbell, A. P. McGuigan
Abstract
In pancreatic ductal adenocarcinoma (PDAC), tumour associated macrophages (TAMs) are a heterogeneous immune cell population that interact with cancer cells to promote malignancy, chemo-resistance, and immunosuppression. Aside from TAMs, hypoxia is a prominent feature of PDAC that can rewire cells to survive and enhance malignancy in the tumour microenvironment (TME). Deciphering the interactions between macrophages, cancer cells and hypoxia could lead to the development of effective immune-targeted therapies for PDAC. However, there are only a few models that physiologically recapitulate the PDAC TME and allow for meaningful interrogation of cancer-immune cell interactions in hypoxia. Here, we develop a model of primary macrophages and PDAC patient organoid-derived cells by adapting TRACER, a paper-based, engineered 3D model that allows snapshot analysis of cellular response in hypoxia. In this study, we establish a direct co-culture method of primary macrophages and PDAC organoid cells in TRACER and demonstrate that TRACER co-cultures generate hypoxic gradients and show expected phenotypic responses to this hypoxic gradient. Moreover, we report for the first time in a human in vitro model that hypoxic macrophages exert a graded chemoprotective effect on gemcitabine-treated PDAC organoid cells, and that interactions between cancer cells and macrophages from the inner layers of TRACER indirectly attenuate the inflammatory response of donor-derived T-cells. Overall, the TRACER co-culture system is a novel, fully human 3D in vitro cancer-immune model for evaluating the response of macrophages and cancer cells in a hypoxic gradient.
- organism: human
- assay: organoid / primary culture
- research focus: cell-cell communication
- research focus: drug response / drug discovery
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In vitro model of inflammatory, hypoxia, and cancer stem cell signaling in pancreatic cancer using heterocellular 3-dimensional spheroids
Megha Suresh, George Mattheolabakis, … Mansoor Amiji·bioRxiv·Oct 26, 2018
- SpheroMap Cytometry: a novel spatial flow cytometry approach to evaluate immune response in PDAC spheroids
Sara E. Castro-Silva, Camila Bonaldo, … Rodrigo Alexandre Panepucci·bioRxiv·Aug 8, 2025
- Multi-omics and functional analysis of a bioengineered vascularized pancreatic cancer model reveal an immunosuppressive and therapy-resistant niche
Giulio Giustarini, Kok Siong Ang, … Giulia Adriani·bioRxiv·Mar 9, 2026
- Tumor-associated tissue-resident macrophages drive pancreatic cancer progression through IGF1-IGF1R signaling
Yuya Yamamoto, Kenta Takeuchi, … Hideki Taniguchi·bioRxiv·May 12, 2026
- Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment
Y. Huang, C. J. Garcia Garcia, … C. M. Taniguchi·bioRxiv·May 21, 2021
- CTHRC1+ Fibroblasts and SPP1+ Macrophages Synergistically Contribute to Pro-Tumorigenic Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
Evan Li, Hoi Ching Cheung, Shuangge Ma·Scientific ReportsPeer-reviewed·Jul 29, 2024